Henry Schein, Inc. $HSIC Shares Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC lifted its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 40.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 173,858 shares of the company’s stock after buying an additional 50,308 shares during the period. Hsbc Holdings PLC’s holdings in Henry Schein were worth $12,765,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. AQR Capital Management LLC boosted its stake in Henry Schein by 47.3% in the first quarter. AQR Capital Management LLC now owns 30,402 shares of the company’s stock valued at $2,071,000 after acquiring an additional 9,756 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Henry Schein by 1.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company’s stock worth $1,155,000 after purchasing an additional 229 shares in the last quarter. Acadian Asset Management LLC acquired a new stake in shares of Henry Schein during the first quarter worth about $676,000. Cetera Investment Advisers lifted its holdings in shares of Henry Schein by 12.9% in the 2nd quarter. Cetera Investment Advisers now owns 5,561 shares of the company’s stock valued at $406,000 after purchasing an additional 637 shares during the last quarter. Finally, First Trust Advisors LP boosted its position in shares of Henry Schein by 0.8% in the 2nd quarter. First Trust Advisors LP now owns 221,130 shares of the company’s stock valued at $16,154,000 after purchasing an additional 1,669 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. BTIG Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research note on Thursday, June 11th. Robert W. Baird set a $97.00 price objective on Henry Schein in a research note on Wednesday, May 6th. Mizuho decreased their price objective on Henry Schein from $88.00 to $82.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. BMO Capital Markets assumed coverage on shares of Henry Schein in a research report on Wednesday, July 8th. They set a “market perform” rating and a $85.00 target price on the stock. Finally, UBS Group reaffirmed a “neutral” rating and issued a $85.00 target price (down from $87.00) on shares of Henry Schein in a report on Wednesday, May 6th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Henry Schein currently has an average rating of “Hold” and a consensus target price of $87.64.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Director William K. Daniel purchased 10,000 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were purchased at an average cost of $69.19 per share, for a total transaction of $691,900.00. Following the completion of the purchase, the director directly owned 20,000 shares in the company, valued at $1,383,800. This represents a 100.00% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.89% of the stock is currently owned by company insiders.

Henry Schein Trading Down 1.1%

NASDAQ HSIC opened at $84.93 on Thursday. The company has a quick ratio of 0.75, a current ratio of 1.36 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $9.67 billion, a P/E ratio of 25.66, a P/E/G ratio of 1.65 and a beta of 0.81. Henry Schein, Inc. has a 52-week low of $61.94 and a 52-week high of $89.34. The firm has a 50-day moving average price of $80.49 and a 200 day moving average price of $77.93.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.12. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The company had revenue of $3.37 billion for the quarter, compared to analyst estimates of $3.34 billion. During the same quarter in the previous year, the company earned $1.15 EPS. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities research analysts expect that Henry Schein, Inc. will post 5.32 EPS for the current year.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.